Franklin Resources Inc Pfizer Inc Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

A detailed history of Franklin Resources Inc transactions in Pfizer Inc stock. As of the latest transaction made, Franklin Resources Inc holds 19,879,959 shares of PFE stock, worth $570 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

19,879,959

Previous 20,575,600 3.38%

Holding current value

$570 Million

Previous $592 Million 6.87%

% of portfolio

0.18%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $18 Million - $20.7 Million	-695,641 Reduced 3.38%	19,879,959 $552 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $15.9 Million - $20.7 Million	-610,308 Reduced 2.88%	20,575,600 $592 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $29.3 Million - $34.3 Million	-913,302 Reduced 4.13%	21,185,908 $703 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $43.8 Million - $50.7 Million	-1,213,488 Reduced 5.21%	22,099,210 $811 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $264 Million - $344 Million	6,711,614 Added 40.43%	23,312,698 $951 Million

Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $145 Million - $190 Million	-3,483,546 Reduced 17.34%	16,601,084 $851 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $23.4 Million - $28.6 Million	-535,272 Reduced 2.6%	20,084,630 $879 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $269 Million - $319 Million	-5,788,196 Reduced 21.92%	20,619,902 $1.08 Billion
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $814 Million - $1.01 Billion	-17,783,326 Reduced 40.24%	26,408,098 $1.37 Billion
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $73.9 Million - $110 Million	-1,788,867 Reduced 3.89%	44,191,424 $2.61 Billion
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $403 Million - $518 Million	10,270,562 Added 28.76%	45,980,291 $1.98 Billion
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $329 Million - $372 Million	9,156,521 Added 34.48%	35,709,729 $1.4 Billion
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $252 Million - $285 Million	7,532,823 Added 39.6%	26,553,208 $962 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $142 Million - $180 Million	-4,228,735 Reduced 18.19%	19,020,385 $700 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $340 Million - $399 Million	-10,719,165 Reduced 31.56%	23,249,120 $853 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $166 Million - $202 Million	5,514,934 Added 19.38%	33,968,285 $1.31 Billion
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $12.3 Million - $17.6 Million	-454,801 Reduced 1.57%	28,453,351 $929 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $613,266 - $695,979	-18,629 Reduced 0.06%	28,908,152 $1.13 Billion
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $1.58 Million - $2.05 Million	48,703 Added 0.17%	28,926,781 $1.04 Billion
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $30.5 Million - $34.3 Million	-825,702 Reduced 2.78%	28,878,078 $1.25 Billion
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $18.7 Million - $20.6 Million	-499,264 Reduced 1.65%	29,703,780 $1.26 Billion
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $262 Million - $298 Million	-6,803,172 Reduced 18.38%	30,203,044 $1.32 Billion
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $391 Million - $474 Million	-11,333,372 Reduced 23.45%	37,006,216 $1.63 Billion
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $124 Million - $132 Million	3,761,665 Added 8.44%	48,339,588 $1.75 Billion
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $15.5 Million - $18 Million	-485,081 Reduced 1.08%	44,577,923 $1.58 Billion
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $25.3 Million - $26.8 Million	-759,268 Reduced 1.66%	45,063,004 $1.63 Billion
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.42 Billion - $1.56 Billion	45,822,272	45,822,272 $1.64 Billion

Others Institutions Holding PFE

# of Institutions

3,154

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Pfizer Inc Transaction History